Research team preserves therapeutics in powder form in proof-of-concept experiment

October 10, 2017 by Khadija Elkharbibi, Johns Hopkins University

A team of biological engineers from the Johns Hopkins Applied Physics Laboratory have discovered a way to store and transport at high temperatures certain types of medicines that would typically require freezing and cold storage. Their proof-of-concept experiment has significant implications for medical access in the developing world.

For the study, published online in the Journal of the Royal Society Interface, the team stabilized and preserved "cell-free" expression reagents—living-cell components that contain the cellular machinery to produce new proteins. The preservation method, developed by the study's lead author, David Karig, involves drying the protein expression reagents into a powder in the open air. When these powdered cell extracts are later combined with water and specific DNA types, the mixture creates reactions that produce proteins for therapeutics or vaccines, depending on what type of DNA is used.

Typically, the preserved cell-free protein expression reagents are unstable above freezing temperatures, making cold storage a necessity, which in turn makes this kind of treatment unsustainable in developing countries and remote parts of the world. In disaster scenarios, this preservation method could facilitate fast distribution and production of important field vaccines.

"Our method allows systems to withstand months of heat stress under atmospheric conditions," Karig said. "The resulting ability to efficiently produce proteins with reagents that can be easily stored and distributed under harsh conditions overcomes many of the challenges associated with implementation of novel therapeutics in remote areas."

To demonstrate the application potential of their findings, the researchers mixed DNA with the powdered cell extracts to create a reaction that produced pyocin proteins. These proteins combat Pseudomonas aeruginosa, a common antibiotic-resistant pathogen that can cause pneumonia, urinary tract infections, soft tissue infections, and sepsis. The powdered cell extracts were 136 days old and had been stored at 97.5 degrees Fahrenheit (typical body temperature). According to their findings, the researchers were able to produce enough pyocin proteins from the powdered cell extracts and DNA mixture to achieve a 100-fold reduction in the P. aeruginosa survival fraction.

"The pyocin production system provides an effective first-line treatment to prevent wound infections in combat environments or other remote locations where transport of lab-produced therapeutics would be infeasible," Karig said. "As the end of the age of antibiotics draws near, fieldable platforms like the one we present will be a necessary next step for low-cost storage, delivery, and production of novel medicines."

The research team included co-authors Seneca Bessling, Peter Thielen, Sherry Zhang, and Joshua Wolfe.

Explore further: Tiny 'cages' could keep vaccines safe at high temperatures

More information: David K. Karig et al. Preservation of protein expression systems at elevated temperatures for portable therapeutic production, Journal of The Royal Society Interface (2017). DOI: 10.1098/rsif.2016.1039

Related Stories

Tiny 'cages' could keep vaccines safe at high temperatures

April 24, 2017

Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper ...

Using synthetic biology for chlamydia vaccines

September 13, 2017

A multidisciplinary scientific team at Lawrence Livermore National Laboratory (LLNL) has made significant advances in developing a vaccine for chlamydia using synthetic biology, sponsored by a two-year National Institutes ...

Better cell factories for the drugs of the future

June 23, 2017

Pharmaceuticals based on proteins are promising candidates for the treatment of cancer and other severe diseases, but they can be hard to produce. In a new research project, Chalmers researchers will develop new genetically ...

To produce biopharmaceuticals on demand, just add water

September 23, 2016

Researchers at MIT and other institutions have created tiny freeze-dried pellets that include all of the molecular machinery needed to translate DNA into proteins, which could form the basis for on-demand production of drugs ...

Recommended for you

Commercially relevant bismuth-based thin film processing

September 20, 2018

Developing materials suitable for use in optoelectronic devices is currently a very active area of research. The search for materials for use in photoelectric conversion elements has to be carried out in parallel with developing ...

A game of pool in the live cell

September 20, 2018

Cells need to react to environmental changes and maintain a balanced system of signaling cascades within the cell. Proteins outside of the cell, on the cellular surface, inside the cellular membrane, and within the cell orchestrate ...

Nucleation a boon to sustainable nanomanufacturing

September 19, 2018

Calcium carbonate is found nearly everywhere, in sidewalk cement, wall paint, antacid tablets and deep underground. Engineers at Washington University in St. Louis have used a unique set of state-of-the-art imaging techniques ...

Greater than the sum of its parts

September 18, 2018

When it comes to designing and optimizing mechanical systems, scientists understand the physical laws surrounding them well enough to create computer models that can predict their properties and behavior. However, scientists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.